Dongkook Lifescience, the leading Korean contrast media supplier has acquired Anseong Supply Center from Bayer Korea.
Established in 2017 as a spin-out of Dongkook Pharmaceutical, Dongkook Lifescience is the leading Korean manufacturer and supplier of contrast media for computed tomography (CT) and magnetic resonance imaging (MRI).
Dongkook Lifescience has been advised and supported in this acquisition by BGM Associates.
“We are excited to have successfully finalized this transaction with Bayer. The Anseong manufacturing plant and supply center will enable us to significantly expand our fast-growing contrast media business in Korea and internationally. We are extremely grateful to Prof. Maier and his team of BGM Associates who have supported us throughout the entire process and have facilitated the negotiations with Bayer.” - says Mr. Ki-Ho Cheong, CEO of Dongkook Life Science.
Press Release (Korean)
